Celcuity Inc. logo

Celcuity Inc.

NASDAQ:CELC

Overview | Financials
Company Name Celcuity Inc.
Symbol CELC
Currency USD
Price 15.01
Market Cap 555,823,302
Dividend Yield 0%
52-week-range 8.389 - 22.188
Industry Biotechnology
Sector Healthcare
CEO Mr. Brian F. Sullivan
Website https://www.celcuity.com

An error occurred while fetching data.

About Celcuity Inc.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for

Related Stocks

Equillium, Inc. logo

Equillium, Inc.

EQ

0.85 USD

Surrozen, Inc. logo

Surrozen, Inc.

SRZN

8.01 USD

Fortress Biotech, Inc. logo

Fortress Biotech, Inc.

FBIO

1.92 USD

MyMD Pharmaceuticals, Inc. logo

MyMD Pharmaceuticals, Inc.

MYMD

1.81 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

TRVI

3.41 USD

Financials

Numbers are in millions USD

Numbers are in millions USD